🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The safety, tolerability and recommended phase 2 dose (RP2D) of the combina...
Status
Completed
Location
National Cancer Centre Singapore
Start Date
2011-10-03
Trial ID
NCT01570296
Treatments Being Tested
The investigators hypothesized that topical anti-inflammatory treatment cou...
Status
Completed
Location
Davidoff Center, Rabin Medical Center, Beilinson
Start Date
2011-01
Trial ID
NCT01256437
Treatments Being Tested
The purpose of this study is to measure the ability of erlotinib to effecti...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-08
Trial ID
NCT01189435
Treatments Being Tested
The primary objective of this study is to examine if the combination regime...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01580735
Treatments Being Tested
The investigators postulated that the exploitation of the pro-immunogenic e...
Status
Unknown
Location
Hangzhou First People's Hospital
Start Date
2016-05
Trial ID
NCT02787447
Treatments Being Tested
This is a phase III, open label, randomized controlled multi-center global ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-07-24
Trial ID
NCT03529084
Treatments Being Tested
A Phase 1/2 multi-center open-label study of BGB324 (bemcentinib) as a sing...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2015-04-19
Trial ID
NCT02424617
Treatments Being Tested
Patients will receive AZD9291 at a dose of 80 mg once daily. Intracranial r...
Status
Unknown
Location
Shaare Zedek
Start Date
2016-05
Trial ID
NCT02736513
Treatments Being Tested